References
1. News at a glance, Science.  2020;369(6510):1410-1.
2. Brunson JK, McKinnie SMK, Chekan JR, McCrow JP, Miles ZD, Bertrand EM, et al. Biosynthesis of the neurotoxin domoic acid in a blood-forming diatom, Science. 2018;361(6409):1356-8.
3. World leaders are waking up to the ocean’s role in a healthy planet. Nature. 2020; 588(7836):7-8.
4. Scheuer PJ. Some marine ecological phenomena: chemical basis and biomedical potential. Science. 1990;248(4952):173-7.
5. Stengel DB, Connan S. Marine Algae: a Source of Biomass for Biotechnological Applications. Methods Mol Biol. 2015;1308:1-37.
6. Luo X, Zhou X, Lin X, Qin X, Zhang T, Wang J, et al. Antituberculosis compounds from a deep-sea-derived fungus Aspergillus sp. SCSIO Ind09F01. Nat Prod Res. 2017;31(16):1958-62.
7. Besednova NN, Zaporozhets TS, Somova LM, Kuznetsova TA. Review: prospects for the use of extracts and polysaccharides from marine algae to prevent and treat the diseases caused by Helicobacter pylori. Helicobacter. 2015;20(2):89-97.
8. Song S, Peng H, Wang Q, Liu Z, Dong X, Wen C, et al. Inhibitory activities of marine sulfated polysaccharides against SARS-CoV-2, Food Funct. 2020; 11(9):7415-20.
9. Izumida M, Suga K, Ishibashi F, Kubo Y. The Spirocyclic Imine from a Marine Benthic Dinoflagellate, Portimine, Is a Potent Anti-Human Immunodeficiency Virus Type 1 Therapeutic Lead Compound. Mar Drugs. 2019; 17(9):495.
10. Krishnaveni M, Jayachandran S. Inhibition of MAP kinases and down regulation of TNF-alpha, IL-beta and COX-2 genes by the crude extracts from marine bacteria. Biomed Pharmacother. 2009;63(7):469-76.
11. Sayed DA, Soliman AM, Fahmy SR. Echinochrome pigment as novel therapeutic agent against experimentally - induced gastric ulcer in rats. Biomed Pharmacother. 2018;107:90-5.
12. Choi YK, Ye BR, Kim EA, Kim J, Kim MS, Lee WW, et al. Bis (3-bromo-4,5-dihydroxybenzyl) ether, a novel bromophenol from the marine red alga Polysiphonia morrowii that suppresses LPS-induced inflammatory response by inhibiting ROS-mediated ERK signaling pathway in RAW 264.7 macrophages. Biomed Pharmacother. 2018;103:1170-7.
13. FiorucciS, DistruttiE, BifulcoG, D’AuriaMV, ZampellaA. Marine sponge steroids as nuclear receptor ligands. Trends Pharmacol Sci. 2012;33(11):591-601.
14. Pavão MS. Glycosaminoglycans analogs from marine invertebrates: structure, biological effects, and potential as new therapeutics. Front Cell Infect Microbiol. 2014;4:123.
15. Moura Rda M, Aragão KS, de Melo AA, Carneiro RF, Osório CB, Luz PB, et al. Holothuria grisea agglutinin (HGA): the first invertebrate lectin with anti-inflammatory effects. Fundam Clin Pharmacol. 2013;27(6):656-68.
16. Panagos CG, Thomson DS, Moss C, Hughes AD, Kelly MS, Liu Y, et al. Fucosylated chondroitin sulfates from the body wall of the sea cucumber Holothuria forskali: conformation, selectin binding, and biological activity. J Biol Chem. 2014;289(41):28284-98.
17. Zhang HJ, Chen C, Ding L, Shi HH, Wang CC, Xue CH, et al. Sea cucumbers-derived sterol sulfate alleviates insulin resistance and inflammation in high-fat-high-fructose diet-induced obese mice. Pharmacol Res. 2020;160:105191.
18. Wei L, Gao J, Zhang S, Wu S, Xie Z, Ling G, et al. Identification and Characterization of the First Cathelicidin from Sea Snakes with Potent Antimicrobial and Anti-inflammatory Activity and Special Mechanism. J Biol Chem. 2015;290(27):16633-52.
19. SongY, DouH, GongW, LiuX, YuZ, LiE, et al. Bis-N-norgliovictin, a small-molecule compound from marine fungus, inhibits LPS-induced inflammation in macrophages and improves survival in sepsis. Eur J Pharmacol. 2013;705(1-3):49-60.
20. García Pastor P, De Rosa S, De Giulio A, Payá M, Alcaraz MJ. Modulation of acute and chronic inflammatory processes by cacospongionolide B, a novel inhibitor of human synovial phospholipase A2. Br J Pharmacol. 1999;126(1): 301-11.
21. Andersen RJ. Sponging off nature for new drug leads. Biochem Pharmacol. 2017; 139:3-14.
22. Ávila-Román J, Talero E, de Los Reyes C, García-Mauriño S, Motilva V. Microalgae-derived oxylipins decrease inflammatory mediators by regulating the subcellular location of NFκB and PPAR-γ. Pharmacol Res. 2018;128:220-30.
23. Amigó M, Payá M, De Rosa S, Terencio MC. Antipsoriatic effects of avarol-3’-thiosalicylate are mediated by inhibition of TNF-alpha generation and NF-kappaB activation in mouse skin. Br J Pharmacol. 2007;152(3):353-65.
24. Wilson RB, Chen YJ, Sutherland BG, Sawyez CG, Zhang R, Woolnough T, et al. The marine compound and elongation factor 1A1 inhibitor, didemnin B, provides benefit in western diet-induced non-alcoholic fatty liver disease. Pharmacol Res. 2020;161:105208.
25. Gentile D, Patamia V, Scala A, Sciortino MT, Piperno A, Rescifina A. Putative Inhibitors of SARS-CoV-2 Main Protease from A Library of Marine Natural Products: A Virtual Screening and Molecular Modeling Study. Mar Drugs. 2020; 18(4):225.
26. Zahran EM, Albohy A, Khalil A, Ibrahim AH, Ahmed HA, El-Hossary EM, et al. Bioactivity Potential of Marine Natural Products from Scleractinia-Associated Microbes and In Silico Anti-SARS-COV-2 Evaluation. Mar Drugs. 2020;18(12):645.
27. Festa M, Sansone C, Brunet C, Crocetta F, Di Paola L, Lombardo M, et al. Cardiovascular Active Peptides of Marine Origin with ACE Inhibitory Activities: Potential Role as Anti-Hypertensive Drugs and in Prevention of SARS-CoV-2 Infection. Int J Mol Sci. 2020;21(21):8364.
28. Chen X, Han W, Wang G, Zhao X. Application prospect of polysaccharides in the development of anti-novel coronavirus drugs and vaccines. Int J Biol Macromol. 2020;164:331-43.
29. Jang Y, Shin H, Lee MK, Kwon OS, Shin JS, Kim YI, et al. Antiviral activity of lambda-carrageenan against influenza viruses and severe acute respiratory syndrome coronavirus 2. Sci Rep. 2021;11(1):821.
30. Tandon R, Sharp JS, Zhang F, Pomin VH, Ashpole NM, Mitra D, et al. Effective Inhibition of SARS-CoV-2  Entry by Heparin and Enoxaparin Derivatives. J Virol. 2021;95(3):e01987-20.
31. Gupta RK, Apte GR, Lokhande KB, Mishra S, Pal JK. Carbohydrate-Binding Agents: Potential of Repurposing for COVID-19 Therapy. Curr Protein Pept Sci. 2020;21(11):1085-96.
32. Gaudêncio SP, Pereira F. A Computer-Aided Drug Design Approach to Predict Marine Drug-Like Leads for SARS-CoV-2 Main Protease Inhibition. Mar Drugs. 2020;18(12):633.
33. Kalhotra P, Chittepu VCSR, Osorio-Revilla G, Gallardo-Velazquez T. Field-Template, QSAR, Ensemble Molecular Docking, and 3D-RISM Solvation Studies Expose Potential of FDA-Approved Marine Drugs as SARS-CoVID-2 Main Protease Inhibitors. Molecules. 2021;26(4):936.
34. Müller WEG, Neufurth M, Wang S, Tan R, Schröder HC, Wang X. Morphogenetic (Mucin Expression) as Well as Potential Anti-Corona Viral Activity of the Marine Secondary Metabolite Polyphosphate on A549 Cells. Mar Drugs. 2020;18(12):639.
35. Christy MP, Uekusa Y, Gerwick L, Gerwick WH. Natural Products with Potential to Treat RNA Virus Pathogens Including SARS-CoV-2. J Nat Prod. 2021;84(1): 161-82.
36. Hu CS, Tkebuchava T. SEEDi1.0-3.0strategies for major noncommunicable diseases in China. J Integr Med. 2017;15(4):265-9.
37. Hu CS, Wu QH, Hu DY. Cardiovascular, diabetes, and cancer strips: evidences,
mechanisms, and classifications. J Thorac Dis. 2014;6(9):1319-28.
38. Kang HK, Seo CH, Park Y. The effects of marine carbohydrates and glycosylated compounds on human health. Int J Mol Sci. 2015;16(3):6018-56.
39. Wang HD, Li XC, Lee DJ, Chang JS. Potential biomedical applications of marine algae. Bioresour Technol. 2017;244(Pt 2):1407-15.
40. Lee KS, Chun SY, Lee MG, Kim S, Jang TJ, Nam KS. The prevention of TNF-alpha/IFN-gamma mixture-induced inflammation in human keratinocyte and atopic dermatitis-like skin lesions in Nc/Nga mice by mineral-balanced deep sea water. Biomed Pharmacother. 2018;97:1331-40.
41. Ha BG, Moon DS, Kim HJ, ShonYH. Magnesium and calcium-enriched deep-sea water promotes mitochondrial biogenesis by AMPK-activated signals pathway in 3T3-L1 preadipocytes. Biomed Pharmacother. 2016;83:477-84.
42. Lee KS, Kwon YS, Kim S, Moon DS, Kim HJ, Nam KS. Regulatory mechanism of mineral-balanced deep sea water on hypocholesterolemic effects in HepG2 hepatic cells. Biomed Pharmacother. 2017;86:405-13.
43. Lee KS, Lee MG, Woo YJ, Nam KS. The preventive effect of deep sea water on the development of cancerous skin cells through the induction of autophagic cell death in UVB-damaged HaCaT keratinocyte. Biomed Pharmacother. 2019;111: 282-91.
44. Sharifian S, Homaei A, Hemmati R, B Luwor R, Khajeh K. The emerging use of bioluminescence in medical research. Biomed Pharmacother. 2018;101:74-86.

45. Marshall E. Gallo’s institute at the last hurdle. Science. 1996;271(5254):1359.

46. Zhou S, Li L, Perseke M, Huang Y, Wei J, Qin Q. Isolation and characterization of a Klebsiella pneumoniae strain from mangrove sediment for efficient biosynthesis of 1,3-propanediol. Sci Bull. 2015;60(5):511–21.
47. Huang NE, Qiao F. A data driven time-dependent transmission rate for tracking an epidemic: a case study of 2019-nCoV. Sci Bull. 2020;65:425-7.
48. Hu C. Grants supporting research in China. Eur Heart J. 2018;39(25):2342-4.
49. Smith JN, Brown RM, Williams WJ, Robert M, Nelson R, Moran SB. Arrival of the Fukushima radioactivity plume in North American continental waters. Proc Natl Acad Sci U S A. 2015;112(5):1310-5.
50. Bullard EM, Torres I, Ren T, Graeve OA, Roy K. Shell mineralogy of a foundational marine species, Mytilus californianus, over half a century in a changing ocean. Proc Natl Acad Sci U S A. 2021;118(3):e2004769118.
51. Poff KE, Leu AO, Eppley JM, Karl DM, DeLong EF. Microbial dynamics of elevated carbon flux in the open ocean’s abyss. Proc Natl Acad Sci U S A. 2021; 118(4):e2018269118.
52. Angle KJ, Crocker DR, Simpson RMC, Mayer KJ, Garofalo LA, Moore AN, et al. Acidity across the interface from the ocean surface to sea spray aerosol. Proc Natl Acad Sci U S A. 2021;118(2):e2018397118.
53. Hasan NA, Grim CJ, Lipp EK, Rivera IN, Chun J, Haley BJ, et al. Deep-sea hydrothermal vent bacteria related to human pathogenic Vibrio species. Proc Natl Acad Sci U S A. 2015;112(21):E2813-9.
54. Vezzulli L, Grande C, Reid PC, Hélaouët P, Edwards M, Höfle MG, et al. Climate influence on Vibrio and associated human diseases during the past half-century in the coastal North Atlantic. Proc Natl Acad Sci U S A. 2016;113(34): E5062-71.
55. Huang L, Wang Z, Wang H, Zhao L, Jiang H, Zhang B, et al. Nutrition transition and related health challenges over decades in China. Eur J Clin Nutr. 2021;75(2):247-52.
56. Wang ZH, Zhai FY, Wang HJ, Zhang JG, Du WW, Su C, et al. Secular trends in meat and seafood consumption patterns among Chinese adults, 1991-2011. Eur J Clin Nutr. 2015;69(2):227-33.
57. Nestle M. A food lover’s love of nutrition science, policy, and politics. Eur J Clin Nutr. 2019;73(12):1551-5.
58. Soares MJ, Müller MJ. Editorial: Nutrition and COVID-19. Eur J Clin Nutr. 2020;74(6):849.
59. Liu G, Zhang S, Mao Z, Wang W, Hu H. Clinical significance of nutritional risk screening for older adult patients with COVID-19. Eur J Clin Nutr. 2020;74(6):876-83.
60. Zhao X, Xu X, Li X, He X, Yang Y, Zhu S. Emerging trends of technology-based dietary assessment: a perspective study. Eur J Clin Nutr. 2021;75(4):582-7.
61. Thibault R, Coëffier M, Joly F, Bohé J, Schneider SM, Déchelotte P. How the Covid-19 epidemic is challenging our practice in clinical nutrition-feedback from the field. Eur J Clin Nutr. 2021;75(3):407-16.
62. Zhao X, Lin W, Cen S, Zhu H, Duan M, Li W, et al. The online-to-offline (O2O) food delivery industry and its recent development in China. Eur J Clin Nutr. 2021;75(2):232-7.